New partnership with Bora. Read more
January 24, 2026
Ressources
De-Risking the Development of Complex Oral Solid Dosage Forms

Successful drug development begins with identifying and mitigating risks early. From API selection and physicochemical characterization to formulation optimization and clinical manufacturing, decisions made in the earliest stages can significantly impact development timelines, costs, and long-term success.
In this whitepaper, Corealis Pharma explores the critical factors influencing drug formulation success, including solubility, stability, particle properties, and manufacturability. Discover how a science-driven, integrated approach can help pharmaceutical and biotechnology companies overcome development challenges, minimize costly setbacks, and build a stronger foundation for clinical and commercial success.
Download the whitepaper to explore practical strategies for reducing risk throughout the drug development journey.

